Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Medical Oncology|July 28, 2022
Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice GuidelineIrene S Yu, Francine Aubin, Rachel Goodwin, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2014
HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variationBrandon S Sheffield, John Garratt, Steve E Kalloger, et al.
The American Journal of Surgical Pathology|January 31, 2015
BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferationsBrandon S Sheffield, Harry C Hwang, Anna F Lee, et al.
Journal of Medical Economics|July 19, 2022
Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systemsDon Husereau, Terrence Sullivan, Harriet E Feilotter, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support ProgramPhilip Q Ding, Vincent C Tam, Ravi Ramjeesingh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 2015
Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinomaMaziar Riazy, Steve E Kalloger, Brandon S Sheffield, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian PracticesBrandon S Sheffield, Kiefer Eaton, Bruno Emond, et al.
American Journal of Medical Genetics. Part A|November 18, 2015
Paternal uniparental disomy 11p15.5 in the pancreatic nodule of an infant with Costello syndrome: Shared mechanism for hyperinsulinemic hypoglycemia in neonates with Costello and Beckwith-Wiedemann syndrome and somatic loss of heterozygosity in Costello syndrome driving clonal expansionKaren W Gripp, Katherine M Robbins, Brandon S Sheffield, et al.
BMC Cancer|September 6, 2017
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinomaBasile Tessier-Cloutier, Steve E Kalloger, Mohammad Al-Kandari, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion DetectionChristina Bormann Chung, Jeeyun Lee, Marc Barritault, et al.
Pageof 5